Estimated read time: 1-2 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
WASHINGTON, Aug 9, 2006 (UPI via COMTEX) -- U.S. drug regulators may soon permit the over-the-counter sale of a morning-after birth control pill.
That was made possible after the Food and Drug Administration and the pill's maker, Barr Laboratories, agreed on a plan allowing the company to resubmit its application for the birth control pill, known as Plan B, within two weeks, The New York Times reports.
An FDA spokeswoman was quoted as saying her agency would then act quickly on the application.
A regulatory decision on Plan B has been pending for three years with many anti-abortion groups calling it an abortion drug, whereas the drug agency has termed it contraceptive, the report said. Abortion rights supporters have sought easier access to Plan B saying it will help cut abortion rates.
The new agreement would require the application from Barr to restrict Plan B's over-the-counter sales to women older than 18. Those below 18 would get it only with a prescription.
URL: www.upi.com Copyright 2006 by United Press International **********************************************************************
As of Saturday, 08-05-2006 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated an UPTREND on 07-31-2006 for BRL @ $49.86.
For more information on Comtex SmarTrend® Alert, contact your market data provider or go to CSTADirect.com
SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright © 2004-2006 Comtex News Network, Inc. All Rights Reserved.
